 Darya Bubman, PhD
|
| Title(s) | Licensing Officer, Innovation Ventures |
|---|
| School | Chancellor/EVC/FAS |
|---|
| Address | 600 16th St
San Francisco CA 94158
|
|---|
| Phone | 415-237-1585 |
|---|
| vCard | Download vCard |
|---|
|
|
 Overview Darya joined the Office of Innovation, Technology and Alliances (ITA) in November 2011. Her responsibilities include technology management, licensing and outgoing material transfer agreements. Darya earned a B.A. degree in Biochemistry from Cornell University in Ithaca, N.Y. and a Ph.D. in Pharmacology from the Weill Cornell Graduate School of Medical Sciences in New York City. She conducted her doctoral work in the laboratory of Dr. Ethel Cesarman, studying deregulation of cancer signaling pathways by the Kaposi’s sarcoma-associated herpesvirus (KSHV) in primary effusion lymphoma. Following her graduate studies, Darya became an AAAS Science and Technology Policy Fellow and worked at the U.S. State Department in the Intellectual Property Office on international issues related to biomedical IP, innovation, and technology transfer. Prior to joining the ITA, she worked as a Technology Partnerships Manager at the NASA Ames Research Center located at Moffett Field, CA. Darya has a strong background in virology, oncology, pharmacology and molecular biology.
Darya is passionate about working with UCSF faculty and staff to transfer novel UCSF biomedical technologies from bench to bedside.
ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome. Am J Clin Pathol. 2008 Dec; 130(6):957-62.
Czuchlewski DR, Csernus B, Bubman D, Hyjek E, Martin P, Chadburn A, Knowles DM, Cesarman E. PMID: 19019774.
View in: PubMed Mentions: 3 Fields: Translation: Humans
-
EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood. 2008 Apr 01; 111(7):3813-20.
Guasparri I, Bubman D, Cesarman E. PMID: 18230756.
View in: PubMed Mentions: 32 Fields: Translation: HumansCells
-
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen. Oncogene. 2007 Jul 26; 26(34):4979-86.
Bubman D, Guasparri I, Cesarman E. PMID: 17310999.
View in: PubMed Mentions: 47 Fields: Translation: HumansCells
-
Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol. 2005 Jan; 79(2):1244-51.
Fan W, Bubman D, Chadburn A, Harrington WJ, Cesarman E, Knowles DM. PMID: 15613351.
View in: PubMed Mentions: 43 Fields: Translation: HumansCells
-
Pathogenesis of Kaposi's sarcoma. Hematol Oncol Clin North Am. 2003 Jun; 17(3):717-45.
Bubman D, Cesarman E. PMID: 12852653.
View in: PubMed Mentions: 15 Fields: Translation: HumansAnimalsCells
-
Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology. J Lab Clin Med. 2002 Feb; 139(2):116-24.
Birk AV, Bubman D, Broekman MJ, Robertson HD, Drosopoulos JH, Marcus AJ, Szeto HH. PMID: 11919550.
View in: PubMed Mentions: 4 Fields: Translation: AnimalsCells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2002 | 1 | | 2003 | 1 | | 2005 | 1 | | 2007 | 1 | | 2008 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People who share similar concepts with this person.
_
Search Department
_
|